Data from a phase 2 trial of Roche's oral BTK inhibitor fenebrutinib have shown "near-complete suppression" of disease activity and disability progression in relapsing multiple sclerosis (MS).

In amongst a clutch of discontinued phase 3 programmes in Roche's fourth-quarter results update was the news that it has stopped a study of AKT inhibitor ipatasertib as a treatment for first-line ...

Gregor Mendel's principles of inheritance form the cornerstone of modern genetics. So just what are they? When looking at the figure, notice that for each F 1 plant, the self-fertilization ...

A comprehensive and coherent set of mathematics standards for each and every student from prekindergarten through grade 12, Principles and Standards is the first set of rigorous, college and career ...

Preliminary Examination: Current events of national and international importance. Main Examination: General Studies II: Bilateral, regional and global groupings and agreements involving India and/or ...

Merck's injected version of its blockbuster cancer drug Keytruda could face a potential patent challenge from biotech Halozyme Therapeutics , the Wall Street Journal reported on Wednesday, citing ...